SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001144204-18-061802
Filing Date
2018-11-27
Accepted
2018-11-27 19:24:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 4768
  Complete submission text file 0001144204-18-061802.txt   5786
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1